Verdad Advisers »

Eliem Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $990k 145k 6.85

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
Braidwell
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Vanguard Capital Management
Kynam Capital Management
Marshall Wace
Affinity Asset Advisors
Silverarc Capital Management
Driehaus Capital Management
ADAR1 Capital Management
Susquehanna International
Nan Fung Trinity
Sphera Funds Management

View all funds holding Eliem Therapeutics